Friedenthal Financial Invests $49,000 in The Clorox Company (NYSE:CLX)

Friedenthal Financial purchased a new stake in The Clorox Company (NYSE:CLX) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 300 shares of the company’s stock, valued at approximately $49,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Blue Trust Inc. raised its position in Clorox by 34.7% during the 3rd quarter. Blue Trust Inc. now owns 913 shares of the company’s stock worth $149,000 after buying an additional 235 shares during the last quarter. Precedent Wealth Partners LLC lifted its holdings in Clorox by 13.9% in the third quarter. Precedent Wealth Partners LLC now owns 7,736 shares of the company’s stock valued at $1,260,000 after acquiring an additional 942 shares during the period. OmniStar Financial Group Inc. acquired a new position in shares of Clorox during the 3rd quarter worth $824,000. Aspiriant LLC acquired a new stake in shares of Clorox in the third quarter valued at about $202,000. Finally, Stonegate Investment Group LLC acquired a new position in Clorox during the third quarter worth about $219,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 0.4 %

NYSE:CLX opened at $161.96 on Friday. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The Clorox Company has a one year low of $114.68 and a one year high of $169.09. The business’s 50-day simple moving average is $159.28 and its 200 day simple moving average is $145.15. The stock has a market cap of $20.11 billion, a price-to-earnings ratio of 83.92, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. The firm had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. As a group, sell-side analysts predict that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.01%. The ex-dividend date is Wednesday, October 23rd. Clorox’s payout ratio is currently 252.85%.

Wall Street Analysts Forecast Growth

CLX has been the topic of several research reports. Deutsche Bank Aktiengesellschaft upped their target price on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. DA Davidson reissued a “neutral” rating and issued a $153.00 target price on shares of Clorox in a research note on Friday, September 6th. Citigroup raised their price objective on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Evercore ISI lowered their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Finally, BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Six investment analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $150.14.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.51% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.